STEMCELLS INC STEM (NASDAQ) $ 1.17 Change: +0.01 +0.85% | Volume: 124,941

STEMCELLS INC - Fundamental Profile

Company Information

Ticker Symbol: STEM
Exchange: NASD
Contact Info: 3155 Porter Drive Palo Alto CA 94304 650-475-3100
CEO/President: Martin McGlynn
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Stemcells, Inc. is engaged in research aimed at the development of therapies that would use stem and progenitor cells derived from fetal or adult sources to treat, and possibly cure, human diseases and injuries such as Parkinson\'s disease, hepatitis, diabetes, and spinal cord injuries.

Share Information

Shares Outstanding: 80,810 (000) Market Value: 95,450 ($000)
Percentage of Inst.Shareholders: 8.32% Number of Inst.Shareholders: 4.70%
Last Quarter Sales: 0.03 ($Mil.) Last Quarter Net Income: -6.72 ($Mil.)
Last Quarter EPS: -0.08 P/E Ratio: 0
Most Recent Earnings: -0.06 on 02/10/98 Earnings Per Share: -0.35
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64